Skip to main content

Table 3 Changes in the concentrations of specific oxylipins, CRP and WCC between time-points

From: Longitudinal analysis of serum oxylipin profile as a novel descriptor of the inflammatory response to surgery

Analyte

Pre- vs. early

Early vs. late

Pre- vs. late

Fold change

p value

Fold change

p value

Fold change

p value

CRP

30.00 (3.26–36.47)

0.007

1.07 (0.74–2.42)

0.213

13.25 (4.95–34.89)

0.0002

WCC

1.44 (1.25–1.64)

<0.0001

0.78 (0.68–0.86)

0.045

1.15 (0.85–1.47)

0.13

9-HODE

0.71 (0.55–0.90)

0.028

1.01 (0.71–1.46)

0.295

0.71 (0.42–1.48)

0.891

13-HODE

0.72 (0.61–1.10)

0.039

1.06 (0.70–1.60)

0.117

0.73 (0.52–1.47)

0.955

5-HETE

0.89 (0.70–1.22)

0.138

1.13 (0.80–1.62)

0.18

1.04 (0.72–1.71)

0.445

8-HETE

0.74 (0.25–1.18)

0.052

1.54 (1.01–2.54)

0.011

1.28 (0.96–1.72)

0.426

12-HETE

0.86 (0.41–1.74)

0.214

1.62 (0.64–4.46)

0.065

2.57 (0.66–5.95)

0.467

12-Oxo-LTB4

0.53 (0.28–1.05)

0.147

1.00 (0.49–3.16)

0.118

0.51 (0.31–1.00)

0.039

8,9-DHET

0.62 (0.34–0.88)

0.024

1.35 (0.94–3.57)

0.014

0.93 (0.67–1.79)

0.799

5,6-DHET

0.94 (0.08–1.00)

0.035

1.00 (1.00–14.03)

0.151

1.00 (1.00–1.39)

0.226

11,12-DHET

0.70 (0.37–0.93)

0.016

1.23 (0.88–2.06)

0.038

0.87 (0.63–1.28)

0.474

14,15-DHET

0.66 (0.42–0.98)

0.043

1.19 (1.08–1.93)

0.03

1.03 (0.62–1.72)

0.665

PGF2α

0.99 (0.29–1.03)

0.311

1.00 (0.19–6.44)

0.377

1.50 (0.41–7.72)

0.46

6-Keto-PGF1α

1.00 (0.64–1.61)

0.914

1.00 (0.41–1.43)

0.127

1.00 (0.44–1.14)

0.468

TXB2

0.51 (0.05–3.67)

0.227

1.21 (0.25–7.56)

0.365

1.70 (0.23–13.32)

0.769

11-HETE

1.47 (1.18–1.65)

0.005

1.20 (0.89–2.10)

0.068

1.17 (0.60–1.86)

0.756

14-HDoHE

0.96 (0.41–1.76)

0.275

1.26 (0.75–2.56)

0.057

1.51 (0.54–3.01)

0.415

C20:5 (EPA)

0.77 (0.51–1.21)

0.18

1.09 (0.66–1.61)

0.976

0.90 (0.56–1.45)

0.374

C20:4 (AA)

0.92 (0.79–1.29)

0.749

1.14 (0.85–1.50)

0.083

1.19 (0.90–1.62)

0.028

15(S)-HETE

0.63 (0.52–0.94)

0.005

1.22 (0.78–1.46)

0.238

0.81 (0.74–1.31)

0.692

C22:6 (DHA)

0.80 (0.58–1.20)

0.352

1.02 (0.78–1.32)

0.948

0.81 (0.66–1.41)

0.675

17-HDoHE

0.82 (0.63–1.26)

0.122

1.19 (0.75–1.75)

0.098

1.16 (0.73–1.27)

0.778

C20:3 (DGLA)

0.96 (0.66–1.27)

0.51

1.00 (0.79–1.50)

0.584

0.98 (0.76–1.34)

0.879

  1. Values are reported as median fold change (interquartile range). Italics indicate statistically significant comparisons